×
About 905 results

ALLMedicine™ Autoimmune Thyroid Disease Center

Research & Reviews  451 results

Thyroid cancer and thyroid autoimmune disease: A review of molecular aspects and clinic...
https://doi.org/10.1016/j.prp.2020.153098
Pathology, Research and Practice; Dias Lopes NM, Mendonça Lens HH et. al.

Aug 22nd, 2020 - Thyroid cancer (TC) is the most prevalent malignant neoplasm that affects the endocrine system. Hashimoto's thyroiditis (HT), also known as chronic lymphocytic thyroiditis, is the most common autoimmune thyroid disease (AITD) that, together with G...

Quantitative and functional analysis of PD-1 + NK cells in patients with autoimmune thy...
https://doi.org/10.1210/clinem/dgaa569
The Journal of Clinical Endocrinology and Metabolism; Ortega-Rodríguez AC, Martínez-Hernández R et. al.

Aug 21st, 2020 - NK cells have an important role in innate immunity and in the regulation of immune response. The role of NK cells expressing the PD-1 regulatory receptor has not been explored in patients with autoimmune thyroid disease (AITD). To analyze the leve...

Prevalence of latent and overt polyautoimmunity in autoimmune thyroid disease: A system...
https://doi.org/10.1111/cen.14304
Clinical Endocrinology REFERENCES; Botello A, Herrán M et. al.

Aug 1st, 2020 - Thyroid autoimmunity is the most frequent condition involved in polyautoimmunity (PolyA). However, the frequency of latent and overt PolyA in patients with autoimmune thyroid disease (AITD) as the index condition is unknown. Therefore, the purpose...

Development of Autoimmune Thyroid Disease in Multiple Sclerosis Patients Post-Alemtuzum...
https://doi.org/10.1210/clinem/dgaa453
The Journal of Clinical Endocrinology and Metabolism; Sovetkina A, Nadir R et. al.

Jul 15th, 2020 - Alemtuzumab is an anti-CD52 monoclonal antibody used in the treatment of relapsing-remitting multiple sclerosis (MS). Between 20% and 40% of alemtuzumab-treated MS patients develop autoimmune thyroid disease (AITD) as a side effect. The objective ...

Islet, thyroid and transglutaminase antibodies in adult Bulgarian patients with type 1 ...
https://doi.org/10.1007/s12020-020-02395-1
Endocrine Chakarova N, Dimova R et. al.

Jun 26th, 2020 - The aim of the study was to assess the prevalence and relationship of islet antibodies and autoantibodies of the most common associated autoimmune diseases-autoimmune thyroid disease (AITD) and celiac disease, in adult Bulgarian patients with type...

see more →

Clinicaltrials.gov  453 results

Thyroid cancer and thyroid autoimmune disease: A review of molecular aspects and clinic...
https://doi.org/10.1016/j.prp.2020.153098
Pathology, Research and Practice; Dias Lopes NM, Mendonça Lens HH et. al.

Aug 22nd, 2020 - Thyroid cancer (TC) is the most prevalent malignant neoplasm that affects the endocrine system. Hashimoto's thyroiditis (HT), also known as chronic lymphocytic thyroiditis, is the most common autoimmune thyroid disease (AITD) that, together with G...

Quantitative and functional analysis of PD-1 + NK cells in patients with autoimmune thy...
https://doi.org/10.1210/clinem/dgaa569
The Journal of Clinical Endocrinology and Metabolism; Ortega-Rodríguez AC, Martínez-Hernández R et. al.

Aug 21st, 2020 - NK cells have an important role in innate immunity and in the regulation of immune response. The role of NK cells expressing the PD-1 regulatory receptor has not been explored in patients with autoimmune thyroid disease (AITD). To analyze the leve...

Prevalence of latent and overt polyautoimmunity in autoimmune thyroid disease: A system...
https://doi.org/10.1111/cen.14304
Clinical Endocrinology REFERENCES; Botello A, Herrán M et. al.

Aug 1st, 2020 - Thyroid autoimmunity is the most frequent condition involved in polyautoimmunity (PolyA). However, the frequency of latent and overt PolyA in patients with autoimmune thyroid disease (AITD) as the index condition is unknown. Therefore, the purpose...

Development of Autoimmune Thyroid Disease in Multiple Sclerosis Patients Post-Alemtuzum...
https://doi.org/10.1210/clinem/dgaa453
The Journal of Clinical Endocrinology and Metabolism; Sovetkina A, Nadir R et. al.

Jul 15th, 2020 - Alemtuzumab is an anti-CD52 monoclonal antibody used in the treatment of relapsing-remitting multiple sclerosis (MS). Between 20% and 40% of alemtuzumab-treated MS patients develop autoimmune thyroid disease (AITD) as a side effect. The objective ...

Islet, thyroid and transglutaminase antibodies in adult Bulgarian patients with type 1 ...
https://doi.org/10.1007/s12020-020-02395-1
Endocrine Chakarova N, Dimova R et. al.

Jun 26th, 2020 - The aim of the study was to assess the prevalence and relationship of islet antibodies and autoantibodies of the most common associated autoimmune diseases-autoimmune thyroid disease (AITD) and celiac disease, in adult Bulgarian patients with type...

see more →

News  1 results

Fast Five Quiz: How Much Do You Know About Hypothyroidism?
https://www.medscape.com/viewarticle/849695

Aug 23rd, 2015 - Hypothyroidism is a common endocrine disorder resulting from deficiency of thyroid hormone. In the United States and other areas of adequate iodine intake, autoimmune thyroid disease (Hashimoto disease) is the most common cause of hypothyroidism; ...

see more →